ATARA BIOTHERAPEUTICS INC's ticker is ATRA and the CUSIP is 046513107. A total of 112 filers reported holding ATARA BIOTHERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $24,570 | -91.9% | 15,261 | -83.5% | 0.00% | -100.0% |
| Q4 2022 | $303,823 | +575.2% | 92,629 | +682.8% | 0.00% | – |
| Q3 2022 | $45,000 | -99.0% | 11,833 | -95.2% | 0.00% | -100.0% |
| Q3 2021 | $4,406,000 | -41.4% | 246,136 | -49.1% | 0.01% | -41.2% |
| Q2 2021 | $7,518,000 | -45.2% | 483,450 | -49.4% | 0.02% | -52.8% |
| Q1 2021 | $13,724,000 | -29.8% | 955,709 | -4.0% | 0.04% | -35.7% |
| Q4 2020 | $19,542,000 | +183.5% | 995,497 | +87.2% | 0.06% | +133.3% |
| Q3 2020 | $6,893,000 | +298.7% | 531,871 | +348.3% | 0.02% | +166.7% |
| Q2 2020 | $1,729,000 | +150.9% | 118,654 | +46.5% | 0.01% | +50.0% |
| Q1 2020 | $689,000 | -82.6% | 81,003 | -66.3% | 0.01% | -50.0% |
| Q4 2019 | $3,963,000 | +202.3% | 240,631 | +159.2% | 0.01% | +200.0% |
| Q3 2019 | $1,311,000 | +60.7% | 92,832 | +500.0% | 0.00% | 0.0% |
| Q2 2015 | $816,000 | – | 15,473 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Antipodean Advisors LLC | 800,000 | $11,656,000 | 5.38% |
| Consonance Capital Management LP | 5,238,218 | $76,321,000 | 4.57% |
| BRIDGER MANAGEMENT, LLC | 1,785,784 | $26,019,000 | 2.41% |
| Trellus Management Company, LLC | 150,000 | $2,186,000 | 2.37% |
| MAVERICK CAPITAL LTD | 6,754,102 | $98,407,000 | 2.07% |
| Redmile Group, LLC | 6,843,370 | $99,708,000 | 1.84% |
| Baupost Group | 9,922,030 | $144,564,000 | 1.80% |
| Camber Capital Management LP | 1,400,000 | $20,398,000 | 1.17% |
| Pinz Capital Management, LP | 161,100 | $2,347,000 | 1.08% |
| Artal Group S.A. | 2,500,000 | $36,425,000 | 1.02% |